XML 106 R88.htm IDEA: XBRL DOCUMENT
v3.23.1

Stock Options and Performance Share Units (Details Narrative) - USD ($) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 12 Months Ended
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Dec. 29, 2024 | Dec. 29, 2023 | Sep. 01, 2023 | Mar. 01, 2023 | Dec. 29, 2022 | Nov. 11, 2022 | Sep. 01, 2022 | Mar. 01, 2022 | Dec. 29, 2021 | Nov. 02, 2021 | Oct. 07, 2021 | Sep. 02, 2021 | Sep. 01, 2021 | Aug. 06, 2021 | Jul. 23, 2021 | Dec. 31, 2022 | Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of stock options grants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 72,500 | 712,500
Consulting expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 5,418,863 | $ 4,268,684
Consulting expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 4,899,433 | $ 3,920,046
Exercise price |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 2.21 | $ 5.00
Chief Executive Officer [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of stock options grants |  |  |  |  |  |  |  |  | 400,000 |  |  |  |  |  |  |  |
Share based payment award vesting rights, description |  |  |  |  |  |  |  |  | The PSUs were to vest in 5% increments according to a schedule that correlates with the Company’s stock price. The first 5% of the PSUs was to have vested upon the Company’s stock price closing at $3.00. 50% was to have vested at a closing price of $16.50, and 100% was to have vested at a closing price of $31.50. |  |  |  |  |  |  |  |
Fair value |  |  |  |  |  |  |  |  | $ 1,344,570 |  |  |  |  |  |  |  |
Consulting expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 232,312 | $ 0
Director [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of stock options grants |  |  |  |  |  |  |  |  | 300,000 |  |  |  |  |  | 15,000 |  |
Share based payment award vesting rights, description |  |  |  |  |  |  |  |  | The PSUs were to vest in 5% increments according to a schedule that correlates with the Company’s stock price. The first 5% of the PSUs was to have vested upon the Company’s stock price closing at $3.00. 50% was to have vested at a closing price of $16.50, and 100% was to have vested at a closing price of $31.50. |  |  |  |  |  | The stock options vested on January 1, 2022. The fair value of the options on grant date was estimated to be $129,480 |  |
Fair value |  |  |  |  |  |  |  |  | $ 1,344,570 |  |  |  |  |  | $ 129,480 |  |
Consulting expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 799 | 128,681
Expiry date |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Jul. 23, 2026 |  |
Exercise price |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 5.50 |  |
Advisor One [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of stock options grants |  |  |  |  |  |  |  |  |  |  | 5,000 |  |  |  |  | 10,000 |
Fair value |  |  |  |  |  |  |  |  |  |  | $ 353,230 |  |  |  |  | $ 21,780 |
Exercise price |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 2.19 |
Expiry date |  |  |  |  |  |  |  |  |  |  | Oct. 07, 2026 |  |  |  |  | Feb. 07, 2027 |
Exercise price |  |  |  |  |  |  |  |  |  |  | $ 5.50 |  |  |  |  |  |
Advisor Two [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of stock options grants |  |  |  |  |  |  |  |  |  | 62,500 |  |  |  |  |  | 50,000 |
Fair value |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 261,400 |
Consulting expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 32,856 | 320,374
Exercise price |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 2.37 |
Expiry date |  |  |  |  |  |  |  |  |  | Nov. 02, 2026 |  |  |  |  |  | May 05, 2032 |
Exercise price |  |  |  |  |  |  |  |  |  | $ 5.24 |  |  |  |  |  |  |
Advisor [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Consulting expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 283,180 |
Consultants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of stock options grants |  |  |  |  |  |  |  |  |  |  |  | 400,000 |  |  |  | 12,500 |
Share based payment award vesting rights, description |  |  |  |  |  |  |  |  |  |  |  | The options have a vesting period of 6 months from the initial grant date |  |  |  | The options are earned in four equal installments on February 27, 2023, May 29, 2023, August 29, 2023 and November 27, 2023. The options shall vest one year after being earned on February 27, 2024, May 29, 2024, August 29, 2024 and November 27, 2024 |
Fair value |  |  |  |  |  |  |  |  |  |  |  |  | $ 2,112,000 |  |  | $ 18,725 |
Consulting expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,058,917 | 352,972
Exercise price |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1.60 |
Expiry date |  |  |  |  |  |  |  |  |  |  |  | Sep. 01, 2026 |  |  |  | Nov. 29, 2032 |
Consulting expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,642 |
Exercise price |  |  |  |  |  |  |  |  |  |  |  | $ 5.32 |  |  |  |  |
Stock option vested |  |  |  |  |  |  | 100,000 | 100,000 |  |  |  |  |  |  |  |  |
Consultants [Member] | Forecast [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock option vested |  |  | 100,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Consultants [Member] | Subsequent Event [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock option vested |  |  |  | 100,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Officers and Directors [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of stock options grants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,350,000 |
Exercise price |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 0.01 |
Expiry date |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Apr. 12, 2032 |
Directors Advisors and Officers [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of stock options grants |  |  |  |  |  |  |  |  |  |  |  |  |  | 140,000 |  |  |
Share based payment award vesting rights, description |  |  |  |  |  |  |  |  |  |  |  |  |  | The stock options vested on January 1, 2022. The fair value of the options on grant date was estimated to be $754,189. |  |  |
Fair value |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 754,189 |  |  |
Consulting expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 5,105 | 749,084
Expiry date |  |  |  |  |  |  |  |  |  |  |  |  |  | Aug. 06, 2026 |  |  |
Exercise price |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 5.50 |  |  |
Board Of Members [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of stock options grants |  |  |  |  |  |  |  |  | 90,000 |  |  |  |  |  |  |  |
Share based payment award vesting rights, description |  |  |  |  |  |  |  |  | The options have a vesting period of 1 year from the initial grant date |  |  |  |  |  |  |  |
Fair value |  |  |  |  |  |  |  |  | $ 224,280 |  |  |  |  |  |  |  |
Consulting expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 73,941 | $ 0
Expiry date |  |  |  |  |  |  |  |  | Dec. 29, 2026 |  |  |  |  |  |  |  |
Exercise price |  |  |  |  |  |  |  |  | $ 2.51 |  |  |  |  |  |  |  |
Stock option vested |  |  |  |  | 10,000 |  |  |  |  |  |  |  |  |  |  |  |
Board Of Members [Member] | Forecast [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock option vested | 10,000 | 10,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Performance Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of stock options grants |  |  |  |  |  | 700,000 |  |  |  |  |  |  |  |  |  |  |
Share based payment award vesting rights, description |  |  |  |  |  | The PSUs vest in 5% increments according to the modified schedule that correlates with the Company’s stock price. The first 5% of the PSUs vest upon the Company’s stock price closing at $2.25. 50% will have vested at a closing price of $5.31, and 100% will have vested at a closing price of $13.76. |  |  |  |  |  |  |  |  |  |  |
Fair value |  |  |  |  |  | $ 1,254,460 |  |  |  |  |  |  |  |  |  |  |
Consulting expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 35,100 |
2015 Equity Incentive Plan [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share based compensation, description |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | the number of common shares reserved for issuance under the option plan shall not exceed 10% of the issued and outstanding common shares of the Company, have a maximum term of 10 years, and vest at the discretion of the Board of Directors. |

X
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07.2(a),(b),(c),(d)) -URI https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 220 -Section 45 -Paragraph 3 -Subparagraph (k) -URI https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268 + Details
Name: | us-gaap_ProfessionalFees
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of noncash expense for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585 + Details
Name: | us-gaap_ShareBasedCompensation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Date the equity-based award expires, in YYYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Gross number of share options (or share units) granted during the period. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(01) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(02) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(01) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of options vested. + References No definition available. + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=srt_DirectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=WKSP_AdvisorOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=WKSP_AdvisorTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=WKSP_AdvisorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=WKSP_ConsultantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementScenarioAxis=srt_ScenarioForecastMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=WKSP_OfficersAndDirectorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=WKSP_DirectorsAdvisorsandOfficersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=WKSP_BoardOfMembersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=WKSP_TwoThousandFifteenEquityIncentivePlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |